Vaxcyte, Inc. (PCVX) — Financial statements
Income statement, balance sheet, and cash flow for Vaxcyte, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 794↑66.6% | 477↑43.4% | 332↑96.1% | 169↑116.1% | 78 | |
| General & Administrative Expenses | 129↑39.3% | 93↑53.1% | 61↑52.5% | 40↑57.6% | 25 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 129↑39.3% | 93↑53.1% | 61↑52.5% | 40↑57.6% | 25 | |
| Other Expenses | 0.00 | 0.00↓100.0% | 75↑226.2% | 23 | 0.00 | |
| Operating Expenses | 924↑62.2% | 570↑21.7% | 468↑101.5% | 232↑124.0% | 104 | |
| Total Costs & Expenses | 924↑62.2% | 570↑21.7% | 468↑101.5% | 232↑124.0% | 104 | |
| Operating Results | ||||||
| Operating Income | -924↓62.2% | -570↓21.7% | -468↓101.5% | -232↓124.0% | -104 | |
| Depreciation & Amortization | 25↑56.9% | 16↑55.8% | 10↑7.6% | 9↑173.4% | 3 | |
| EBITDA | -742↓65.5% | -448↓14.3% | -392↓83.2% | -214↓121.5% | -97 | |
| EBIT | -767↓65.2% | -464↓15.3% | -402↓80.0% | -223↓123.3% | -100 | |
| Interest & Other Income | ||||||
| Net Interest Income | 120↑8.8% | 110↑74.9% | 63↑653.0% | 8↑2378.9% | 0.34 | |
| Interest Income | 120↑8.8% | 110↑74.9% | 63↑652.8% | 8↑2329.1% | 0.34 | |
| Interest Expense | 0.00 | 0.00 | 0.00↓100.0% | 0.00↓71.4% | 0.01 | |
| Non-Operating Income | -157↓48.7% | -106↓60.6% | -66↓649.7% | -9↓143.7% | -4 | |
| Other Income / Expenses | 157↑48.7% | 106↑60.6% | 66↑649.9% | 9↑144.1% | 4 | |
| Income Before Tax | -767↓65.2% | -464↓15.3% | -402↓80.0% | -223↓123.3% | -100 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -767↓65.2% | -464↓15.3% | -402↓80.0% | -223↓123.3% | -100 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -767↓65.2% | -464↓15.3% | -402↓80.0% | -223↓123.3% | -100 | |
| Bottom-Line Net Income | -767↓65.2% | -464↓15.3% | -402↓80.0% | -223↓123.3% | -100 | |
| EPS (Basic) | -5.63↓48.2% | -3.80↑8.2% | -4.14↓20.3% | -3.44↓78.2% | -1.93 | |
| EPS (Diluted) | -5.63↓48.2% | -3.80↑8.2% | -4.14↓20.3% | -3.44↓78.2% | -1.93 | |
| Weighted Average Shares | 136↑11.6% | 122↑25.6% | 97↑49.8% | 65↑25.0% | 52 | |
| Weighted Average Diluted Shares | 136↑11.6% | 122↑25.6% | 97↑49.8% | 65↑25.0% | 52 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.